Physician profile
Olga Brushaber
NPI 1306259627
$9,476.69
in general payments reported to CMS, 2019-2025
33 companies · $2,099 in 2025
The $2,099 reported for 2025 was more than what 80% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $258 · 2021: $882 · 2022: $1,216 · 2023: $2,012 · 2024: $2,512 · 2025: $2,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,524 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,524.04 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,772.59 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Janssen Biotech, INC. | $1,422.03 | 2020-2025 | Tremfya, Stelara, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $502.47 | 2020-2025 | Entyvio, Eohilia, Gattex |
| Pfizer INC. | $493.68 | 2022-2025 | |
| Celgene Corporation | $476.68 | 2021-2024 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $358.41 | 2019-2025 | Xifaxan, Plenvu, Relistor |
| Gilead Sciences, INC. | $339.04 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $287.38 | 2022-2025 | Dupixent |
| Genzyme Corporation | $248.36 | 2022-2025 | |
| Qol Medical, LLC | $161.79 | 2020-2025 | Sucraid, Sucraid |
| Janssen Scientific Affairs, LLC | $156.45 | 2024-2025 | Tremfya, Stelara |
| Evoke Pharma, INC. | $135.52 | 2023 | Gimoti |
| Ironwood Pharmaceuticals, INC | $130.64 | 2021-2024 | Linzess |
| Ardelyx, INC. | $128.25 | 2022-2025 | Ibsrela |
| Medtronic, INC. | $115.39 | 2024 | Signia |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $89.59 | 2023-2025 | Zenpep |
| Sandoz INC. | $85.87 | 2023-2024 | Hyrimoz |
| Merck Sharp & Dohme LLC | $82.63 | 2021-2024 | Dificid |
| Intercept Pharmaceuticals, INC. | $73.98 | 2023-2024 | Ocaliva |
| Lilly USA, LLC | $59.50 | 2024 | Omvoh |
| Phathom Pharmaceuticals, INC. | $53.63 | 2024-2025 | Voquezna |
| Daiichi Sankyo INC. | $47.64 | 2021-2025 | Injectafer |
| Novo Nordisk INC | $46.08 | 2025 | Wegovy |
| Organon LLC | $32.40 | 2023-2024 | Renflexis |
| Redhill Biopharma INC. | $30.85 | 2021 | |
| Madrigal Pharmaceuticals | $26.54 | 2024 | Resmetirom |
| Nestle Healthcare Nutrition INC. | $21.97 | 2021 | |
| Endo Pharmaceuticals INC. | $21.47 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $20.81 | 2024 | Iqirvo |
| Capsovision, INC. | $17.36 | 2025 | Capsocam Plus |
| Braintree Laboratories, INC. | $13.50 | 2023 | Suflave |
| Ethicon US, LLC | $12.94 | 2022 | |
| Shionogi INC | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Brushaber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.